Israel Englander Aquestive Therapeutics, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Aquestive Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 258,216 shares of AQST stock, worth $658,450. This represents 0.0% of its overall portfolio holdings.

Number of Shares

258,216

Previous 87,227 196.03%

Holding current value

$658,450

Previous $308,000 142.86%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$2.54 - $3.75 $434,312 - $641,208	170,989 Added 196.03%	258,216 $748,000
Q4 2024 Feb 14, 2025	BUY	$3.46 - $5.64 $158,903 - $259,022	45,926 Added 111.2%	87,227 $308,000
Q3 2024 Nov 14, 2024	SELL	$2.4 - $5.09 $118,946 - $252,265	-49,561 Reduced 54.55%	41,301 $205,000
Q2 2024 Aug 14, 2024	SELL	$2.31 - $4.5 $932,276 - $1.82 Million	-403,583 Reduced 81.62%	90,862 $236,000
Q1 2024 May 15, 2024	BUY	$2.01 - $6.09 $731,563 - $2.22 Million	363,962 Added 278.93%	494,445 $2.11 Million
Q4 2023 Feb 14, 2024	SELL	$1.29 - $2.47 $248,277 - $475,383	-192,463 Reduced 59.6%	130,483 $263,000
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $21,303 - $50,044	20,098 Added 6.64%	322,946 $532,000
Q1 2023 May 15, 2023	BUY	$0.72 - $1.15 $184,728 - $295,053	256,568 Added 554.38%	302,848 $345,000
Q4 2022 Feb 14, 2023	SELL	$0.77 - $1.18 $330,785 - $506,917	-429,591 Reduced 90.27%	46,280 $42,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $1.73 $398,722 - $1.09 Million	-632,893 Reduced 57.08%	475,871 $557,000
Q2 2022 Aug 15, 2022	BUY	$0.64 - $2.57 $543,093 - $2.18 Million	848,584 Added 326.15%	1,108,764 $709,000
Q1 2022 May 16, 2022	SELL	$2.28 - $4.26 $225,024 - $420,440	-98,695 Reduced 27.5%	260,180 $679,000
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $129,522 - $223,593	35,101 Added 10.84%	358,875 $1.4 Million
Q3 2021 Nov 15, 2021	SELL	$3.25 - $4.66 $370,760 - $531,612	-114,080 Reduced 26.05%	323,774 $1.41 Million
Q2 2021 Aug 16, 2021	BUY	$3.29 - $5.21 $1.44 Million - $2.28 Million	437,854 New	437,854 $1.74 Million
Q1 2021 May 17, 2021	SELL	$4.17 - $6.73 $156,141 - $251,998	-37,444 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$4.65 - $7.79 $174,114 - $291,688	37,444 New	37,444 $200,000
Q3 2020 Nov 16, 2020	SELL	$4.12 - $9.09 $634,673 - $1.4 Million	-154,047 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$1.84 - $6.44 $153,358 - $536,754	-83,347 Reduced 35.11%	154,047 $749,000
Q1 2020 May 14, 2020	SELL	$1.54 - $6.75 $191,917 - $841,198	-124,622 Reduced 34.42%	237,394 $520,000
Q4 2019 Feb 14, 2020	BUY	$3.06 - $8.78 $801,496 - $2.3 Million	261,927 Added 261.69%	362,016 $2.11 Million
Q3 2019 Nov 14, 2019	SELL	$3.04 - $4.91 $504,801 - $815,320	-166,053 Reduced 62.39%	100,089 $318,000
Q2 2019 Aug 14, 2019	BUY	$3.72 - $6.95 $990,048 - $1.85 Million	266,142 New	266,142 $1.12 Million
Q1 2019 May 14, 2019	SELL	$5.74 - $8.05 $132,077 - $185,230	-23,010 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.09 - $18.0 $140,130 - $414,180	23,010 New	23,010 $145,000

Others Institutions Holding AQST

# of Institutions

129

Shares Held

44.5M

Call Options Held

44.6K

Put Options Held

182K

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $136M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account